sandoz SA
99.1 FTEThe score of sandoz shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +19 % Equity +44 % Total assets +33 % Headcount (avg FTE) -9 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
sandoz's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 07 Jun 2023
- Year ended 31 Dec 2021filed on 08 Jun 2022
sandoz's financial analysis
- Solvency30.3%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of sandoz
sandoz's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0457.517.227
- VAT number
- BE0457517227
- Peppol
- Registered · 0208:0457517227 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 14 Mar 1996
- Registered office
- 1831 Machelen (Brab.)
- Size
- Medium · 99.1 FTE
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
sandoz (SA) has been based in Machelen (Brab.) since 1996, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €115.3m, a net profit of €3.21m and equity of €16.8m. With 99.1 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 30.3%, below the median of its sector (46.0%).
Companies similar to sandoz
Companies in the same business, of comparable size and area, outside its group.
- Gilead Sciences Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €68.7m
- O&M Halyard Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €45.9m
- Haleon Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €29.4m
- Takeda Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €86.4m
- MED Concept Europe Wholesale of pharmaceutical and medical goods Woluwe-Saint-Pierre · balance sheet €18.7m
- Omrix Biopharmaceuticals Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €66.5m
- Elekta Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €13.1m
- Chiesi Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €32.4m
Frequently asked questions about sandoz
What is the revenue of sandoz?
According to the 2025 annual accounts filed with the NBB, the revenue of sandoz amounts to 115,301,278 €.
What is the VAT number of sandoz?
In Belgium, the VAT number is the company number prefixed with BE: BE0457517227 for sandoz, if the company is VAT-registered. Its company number (CBE) is 0457.517.227.
Where is the registered office of sandoz?
According to the CBE register, the registered office of sandoz is in 1831 Machelen (Brab.).
What is the equity of sandoz?
At the close of the 2025 financial year, the equity of sandoz amounts to 16,786,397 €, a solvency of 30.3% of total assets.
How many people work at sandoz?
99.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages sandoz?
The register lists 2 active mandates at sandoz. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of sandoz
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →